SEBACEOUS GLAND CARCINOMA OF THE EYELIDS
Keywords:
Sebaceous, gland, eyelid, carcinomaAbstract
Objective: To analyze the clinical presentation and treatment response of Sebaceous Gland Carcinoma (SGC) of the
eyelid in our working setup.
Material & Methods: It was a retrospective, non-comparative, observational case series study, conducted at the
Department of Ophthalmology, Dow Medical College & Civil Hospital, Karachi and the Department of Ophthalmology
Sindh Govt. Qatar Hospital Karachi, over a period of twenty three years from January 1985 to December 2008. In this
study fifteen patients with histo-pathologically confirmed Sebaceous Gland Carcinoma (SGC) treated at different
places were subjected to retrospective analysis. Clinical data of all patients including patients’ history, clinical
features, therapy, and outcome were collected from the hospital records.
Results: Nine men (60%) and 6 women (40%) with a mean age of 55 years (range: 41-80 years) were treated for SGC
on pathological diagnosis by excision biopsy. Majority of the cases i.e. 11 (73.33%) involved the lower eye lid. The
initial diagnosis had been correct in only 3 cases (20%) of the 15 cases with majority of the patients, 8 (53%) being
mislabeled as having chalazion. The major age group involved was between 66-75 years with 33% of the cases. The
tumor was generally 5-10 mm in size. All the 15 cases underwent primary surgical excision and were subsequently
followed for a minimum of one year with no recurrence.
Conclusion: Early diagnosis and consequent surgical therapy of SGC of the eyelid leads to a better outcome and
higher survival rates than generally assumed.
Downloads
Published
How to Cite
Issue
Section
License
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
